The DOI matches its Crossref record.
Cost-Effectiveness in Health and Medicine
Abstract
Abstract As healthcare costs rise in the United States, debate is ongoing over how to obtain better value for dollars spent. In this context, the use of cost-effectiveness analysis (CEA) is more compelling than ever. This book, written by the Second Panel on Cost-Effectiveness in Health and Medicine, reviews key concepts and analytic challenges in CEA. The authors endorse the original Panel’s concept of a reference case and support its recommendation that analysts take a broad societal perspective; in addition, they recommend a healthcare sector perspective for a second reference case, as well as an important new framework, the Impact Inventory, for detailing costs and effects. The revisions draw on advances in the field and include three new chapters that capture research on decision modeling, methods for evidence synthesis, and ethical considerations. The volume also includes two new worked examples (Appendix A and Appendix B) to illustrate ways to implement the authors’ recommendations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Sorted by citations
Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.12195 · Cited by 3,069
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847
Goldemberg, D., Azevedo, J. P., Iqbal, S. A., Hasan, A., & Geven, K. (2020) · doi:10.1596/1813-9450-9284 · Cited by 476
Reflections on 10 years of effectiveness-implementation hybrid studies
Curran, G. M., Landes, S. J., McBain, S. A., Pyne, J. M., Smith, J. D., Fernandez, M. E., Chambers, D. A., & Mittman, B. S. (2022) · Frontiers in Health Services · doi:10.3389/frhs.2022.1053496 · Cited by 299
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Verguet, S., Kim, J. J., & Jamison, D. T. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0414-z · Cited by 251
Eisman, A. B., Kilbourne, A. M., Dopp, A. R., Saldana, L., & Eisenberg, D. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.008 · Cited by 210
How to measure costs and benefits of ehealth interventions: An overview of methods and frameworks
Bergmo, T. S. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4521 · Cited by 181
Cost data in implementation science: categories and approaches to costing
Gold, H. T., McDermott, C., Hoomans, T., & Wagner, T. H. (2022) · Implementation Science · doi:10.1186/s13012-021-01172-6 · Cited by 152
Cost Effectiveness of Childhood Obesity Interventions
Gortmaker, S. L., Long, M. W., Resch, S. C., Ward, Z. J., Cradock, A. L., Barrett, J. L., Wright, D. R., Sonneville, K. R., Giles, C. M., Carter, R. C., et al. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.03.032 · Cited by 144
Mixed-method approaches to strengthen economic evaluations in implementation research
Dopp, A. R., Mundey, P., Beasley, L. O., Silovsky, J. F., & Eisenberg, D. (2019) · Implementation Science · doi:10.1186/s13012-018-0850-6 · Cited by 118
Peterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.09.009 · Cited by 130
Hong, J. C., Blankstein, R., Shaw, L. J., Padula, W. V., Arrieta, A., Fialkow, J. A., Blumenthal, R. S., Blaha, M. J., Krumholz, H. M., & Nasir, K. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.04.014 · Cited by 101
Jones, P. R., Somoskeöy, T., Chow-Wing-Bom, H., & Crabb, D. P. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0242-6 · Cited by 79
Datta, S. K., Warshaw, E. M., Edison, K. E., Kapur, K., Thottapurathu, L., Moritz, T. E., Reda, D. J., & Whited, J. D. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.2362 · Cited by 72
Estimating Costs of an Implementation Intervention
Wagner, T. H., Yoon, J., Jacobs, J. C., So, A., Kilbourne, A. M., Yu, W., & Goodrich, D. E. (2020) · Medical Decision Making · doi:10.1177/0272989x20960455 · Cited by 59
Bowser, D. M., Henry, B. F., & McCollister, K. E. (2021) · Implementation Science · doi:10.1186/s13012-021-01094-3 · Cited by 61
Yang, C.-Y., Chen, Y.-R., Ou, H.-T., & Kuo, S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01211-4 · Cited by 51
Chuvarayan, Y., Finger, R. P., & Köberlein-Neu, J. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-019-01115-5 · Cited by 51
Herman, P. M., Mahrer, N. E., Wolchik, S. A., Porter, M. M., Jones, S., & Sandler, I. N. (2015) · Prevention Science · doi:10.1007/s11121-014-0527-6 · Cited by 50
Barbosa, C., Fraser, H., Hoerger, T. J., Leib, A., Havens, J. R., Young, A., Kral, A., Page, K., Evans, J., Zibbell, J., et al. (2019) · Addiction · doi:10.1111/add.14731 · Cited by 48
de Oliveira, C., Cho, E., Kavelaars, R., Jamieson, M., Bao, B., & Rehm, J. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30145-0 · Cited by 44
Ma, J., Yank, V., Lv, N., Goldhaber-Fiebert, J. D., Lewis, M. A., Kramer, M. K., Snowden, M. B., Rosas, L. G., Xiao, L., & Blonstein, A. C. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.06.010 · Cited by 45
Monetary conversion factors for economic evaluations of substance use disorders
McCollister, K., Yang, X., Sayed, B., French, M. T., Leff, J. A., & Schackman, B. R. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.07.008 · Cited by 43
A Prescription for Achieving Equitable Access to Antiobesity Medications
Wright, D. R., Guo, J., & Hernandez, I. (2023) · JAMA Health Forum · doi:10.1001/jamahealthforum.2023.0493 · Cited by 42
Saracutu, M., Rance, J., Davies, H., & Edwards, D. J. (2018) · International journal of osteopathic medicine · doi:10.1016/j.ijosm.2017.10.005 · Cited by 39
Alarid-Escudero, F., Krijkamp, E., Enns, E. A., Yang, A., Hunink, M. G. M., Pechlivanoglou, P., & Jalal, H. (2023) · Medical Decision Making · doi:10.1177/0272989x221103163 · Cited by 39
Hayek, M. A., Giannouchos, T., Lawley, M., & Kum, H.-C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.44372 · Cited by 32
Preblick, R., Kwong, W. J., White, R. H., & Goldhaber, S. Z. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1099412 · Cited by 28
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
Flam-Ross, J. M., Marsh, E., Weitz, M., Savinkina, A., Schackman, B. R., Wang, J., Madushani, R. W. M. A., Morgan, J. R., Barocas, J. A., Walley, A. Y., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.29583 · Cited by 21
Slesnick, N., Chavez, L., Bunger, A., Famelia, R., Ford, J., Feng, X., Higgins, S., Holowacz, E., Jaderlund, S., Luthy, E., et al. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00237-7 · Cited by 20
Lee, T., Kuo, S., Yang, C., & Ou, H. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14188 · Cited by 18
Michaud, T. L., Wilson, K. E., Katula, J. A., You, W., & Estabrooks, P. A. (2023) · Translational Behavioral Medicine · doi:10.1093/tbm/ibad008 · Cited by 12
Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease
Kumar, R., Sporn, K., Borole, A., Khanna, A., Gowda, C., Paladugu, P., Ngo, A., Jagadeesan, R., Zaman, N., & Tavakkoli, A. (2025) · Diagnostics · doi:10.3390/diagnostics15111418 · Cited by 10
Faller, J., Le, L. K.-D., Chatterton, M. L., Perez, J. K., Chiotelis, O., Tran, H. N. Q., Sultana, M., Hall, N., Lee, Y. Y., Chapman, C., et al. (2023) · BJPsych Open · doi:10.1192/bjo.2023.515 · Cited by 6
Metadata
- Venue
- Oxford University Press eBooks
- Publisher
- Oxford University Press
- Published
- 2016-12-12
- OpenAlex
- W2984280663
- Cited by
- 1,552
- References
- 0
- Citations by year
- 2026: 58 · 2025: 102 · 2024: 105 · 2023: 94 · 2022: 106 · 2021: 183 · 2020: 164 · 2019: 167 · 2018: 141 · 2017: 109 · 2016: 101
- FWCI
- 181.94
- Type
- book
- Language
- en
- Open access
- closed
- Locations
- Oxford University Press eBooks (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- cost-effectiveness analysis, reference case, societal perspective, decision models, evidence synthesis, ethical considerations, health care costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
